Assertio Holdings, Inc. (NASDAQ:ASRT) Shares Acquired by Palumbo Wealth Management LLC

Palumbo Wealth Management LLC boosted its holdings in Assertio Holdings, Inc. (NASDAQ:ASRT) by 10.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 205,598 shares of the company’s stock after purchasing an additional 19,637 shares during the quarter. Palumbo Wealth Management LLC owned about 0.22% of Assertio worth $179,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of ASRT. Captrust Financial Advisors purchased a new stake in shares of Assertio in the third quarter valued at about $26,000. Sonora Investment Management Group LLC acquired a new position in Assertio in the 4th quarter valued at about $39,000. Thurston Springer Miller Herd & Titak Inc. raised its stake in Assertio by 33.7% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 67,500 shares of the company’s stock valued at $59,000 after acquiring an additional 17,000 shares during the last quarter. GSA Capital Partners LLP acquired a new stake in Assertio during the 3rd quarter worth approximately $177,000. Finally, XTX Topco Ltd purchased a new position in shares of Assertio in the 3rd quarter valued at approximately $203,000. Institutional investors and hedge funds own 48.96% of the company’s stock.

Assertio Stock Performance

NASDAQ ASRT opened at $0.84 on Friday. The stock has a market capitalization of $80.35 million, a price-to-earnings ratio of -1.15, a PEG ratio of 3.23 and a beta of 0.76. The business’s 50 day moving average is $0.85 and its two-hundred day moving average is $1.02. Assertio Holdings, Inc. has a 12-month low of $0.73 and a 12-month high of $1.80. The company has a current ratio of 2.01, a quick ratio of 1.57 and a debt-to-equity ratio of 0.30.

Insider Activity at Assertio

In other Assertio news, Director Heather L. Mason acquired 75,000 shares of the business’s stock in a transaction on Monday, November 18th. The stock was purchased at an average price of $0.80 per share, for a total transaction of $60,000.00. Following the completion of the transaction, the director now owns 287,650 shares of the company’s stock, valued at $230,120. The trade was a 35.27 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 3.20% of the company’s stock.

Analyst Upgrades and Downgrades

ASRT has been the subject of several analyst reports. HC Wainwright restated a “buy” rating and set a $4.00 price target on shares of Assertio in a research note on Monday, December 16th. StockNews.com raised shares of Assertio from a “hold” rating to a “buy” rating in a research note on Wednesday, November 13th.

About Assertio

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.